The World Health Organization has launched a new procurement agency toimprove access to tuberculosis drugs in developing countries. To be financed by donations, the Global TB Drug Facility will be a mechanism for ensuring increasing access to high-quality drugs, said WHO spokesman Ian Smith, reported by Reuters.
Drug shortages are a major problem for TB patients, he said, noting that only about 25% of patients worldwide are treated in the Directly-Observed Treatment, Short-course (DOTS) program.
Also, the Bill and Melinda Gates Foundation is to provide $10 million over five years for work being done under WHO auspices to develop TB diagnostic tests.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze